HealtheUniverse Announces CEO Dr Vipul Dev MD To Present New Class Of Antibiotics For Wyeth
Healtheuniverse Inc. (OTC: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products announced today CEO Vipul Dev will be presenting, on behalf of Wyeth, a new class of antibiotics for use with infections. The presentation and conference will be this evening and is offered to healthcare professionals.